Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes


About 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the British Journal of Haematology.

New study on morphine treatment in people with COPD and severe, long term breathlessness

Previous article

Rates of carrying loaded handgun double in 4 years

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations